Financhill
Back

Janux Therapeutics Stock Predictions

Janux Therapeutics Stock Forecast

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 50.9% based on the past 3 years of stock performance.
  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Janux Therapeutics Stock Undervalued?
    The current Janux Therapeutics [JANX] share price is $28.80. The Score for JANX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • JANX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Janux Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Janux Therapeutics has on average historically risen by 50.9% based on the past 3 years of stock performance.

Janux Therapeutics Stock Rating

Buy
51
Janux Therapeutics (JANX) is a Buy

Is Janux Therapeutics overpriced?

  • Janux Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Janux Therapeutics Stock Price History

Is JANX stock going to rise?

  • The current trend is relatively stagnant and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
januxrx.com

52-Week Data

52-Week High:
71.71
52-Week Low:
22.52

Prediction Charts

Market Cap:
1.7B
Price in USD:
28.80
Volume:
2M
Beta:
3.34

Technical Analysis

SMA50:
32.99
SMA100:
42.46
SMA200:
44.02
52-Wk Change:
-42.4%

Stock Predictions

  • Is Janux Therapeutics stock public?
    Yes, Janux Therapeutics is a publicly traded company.
  • What is the Janux Therapeutics stock quote today?
    The Janux Therapeutics stock price is 28.80 USD today.
  • How to buy Janux Therapeutics stock online?
    You can buy Janux Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-25 31.72 30.83 32.00 30.25
Mar-26 30.51 30.12 31.02 29.37
Mar-27 30.42 29.78 30.50 29.20
Mar-28 29.80 29.10 30.07 28.91
Mar-31 28.13 27.00 28.13 26.40
Apr-1 27.04 26.81 27.83 26.39
Apr-2 26.40 28.25 28.83 26.03
Apr-3 26.49 26.99 27.41 25.77
Apr-4 26.22 25.77 26.25 24.30
Apr-7 23.72 24.38 25.62 23.40
Apr-8 25.63 23.79 25.63 23.52
Apr-9 23.01 26.83 27.50 22.52
Apr-10 25.54 26.87 27.07 24.92
Apr-11 26.87 28.80 28.90 26.02

Janux Therapeutics Earnings

Janux Therapeutics Earnings Report: Per Share Janux Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Janux Therapeutics Forecast Revenue Growth

Janux Therapeutics Stock Analysis: Historical quarterly revenues per share for Janux Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.34 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.60 per share.

* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.